BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 17885427)

  • 1. Estrogens in vascular biology and disease: where do we stand today?
    Arnal JF; Scarabin PY; Trémollières F; Laurell H; Gourdy P
    Curr Opin Lipidol; 2007 Oct; 18(5):554-60. PubMed ID: 17885427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the controversy about hormonal replacement therapy: insights from estrogen effects on experimental and clinical atherosclerosis.
    Arnal JF; Douin-Echinard V; Tremollières F; Terrisse AD; Sié P; Payrastre B; Guery JC; Bayard F; Gourdy P
    Arch Mal Coeur Vaiss; 2007; 100(6-7):554-62. PubMed ID: 17893638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of inflammatory cytokines in the effect of estradiol on atheroma.
    Gourdy P; Calippe B; Laurell H; Trémollières F; Douin-Echinard V; Lenfant F; Bayard F; Guery JC; Arnal JF
    Clin Exp Pharmacol Physiol; 2008 Apr; 35(4):396-401. PubMed ID: 18307728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding the oestrogen action in experimental and clinical atherosclerosis.
    Arnal JF; Douin-Echinard V; Brouchet L; Tremollières F; Laurell H; Lenfant F; Gadeau AP; Guery JC; Gourdy P
    Fundam Clin Pharmacol; 2006 Dec; 20(6):539-48. PubMed ID: 17109647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Usefulness of experimental models to understand the vascular effects of estrogens].
    Arnal JF; Gourdy P; Garmy-Susini B; Delmas E; Bayard F
    Med Sci (Paris); 2003 Dec; 19(12):1226-32. PubMed ID: 14691747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen receptor actions on vascular biology and inflammation: implications in vascular pathophysiology.
    Arnal JF; Laurell H; Fontaine C; Billon A; Calippe B; Lenfant F; Gourdy P
    Climacteric; 2009; 12 Suppl 1():12-7. PubMed ID: 19811234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Action of natural estrogens on the vessel wall: molecular mechanisms and clinical implications].
    Lüscher TF; Barton M; Wight E; Espinosa E; Yang Z
    Schweiz Med Wochenschr; 1996 Oct; 126(41):1748-55. PubMed ID: 8966507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Vascular protection with estrogen. In-vitro and in-vivo effects--mechanisms and clinical implication].
    Barton M; Wright E; Dai-Do D; Yang Z; Espinosa E; Arnet U; Lüscher TF
    Praxis (Bern 1994); 1997 Jan; 86(5):129-37. PubMed ID: 9064730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Timing of the vascular actions of estrogens in experimental and human studies: why protective early, and not when delayed?
    Lenfant F; Trémollières F; Gourdy P; Arnal JF
    Maturitas; 2011 Feb; 68(2):165-73. PubMed ID: 21167666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estradiol action in atherosclerosis and reendothelialization.
    Arnal JF; Laurell H; Lenfant F; Douin-Echinard V; Brouchet L; Gourdy P
    Ernst Schering Found Symp Proc; 2006; (1):69-86. PubMed ID: 17824172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular cell signaling by membrane estrogen receptors.
    Hisamoto K; Bender JR
    Steroids; 2005; 70(5-7):382-7. PubMed ID: 15862821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Natural estrogens and the cardiovascular system].
    Bader A; Sacrez J; Langer B; Sacrez A
    J Gynecol Obstet Biol Reprod (Paris); 1996; 25(3):233-7. PubMed ID: 8767217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of estrogens on arterial physiology and mechanisms of their atherosclerosis-protective effect in animals].
    Arnal JF; Batkaï S; Elhage R; Darblade B; Rami J; Maret A; Bayard F
    Therapie; 1999; 54(3):339-46. PubMed ID: 10500448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of the inflammatory response by estrogens with focus on the endothelium and its interactions with leukocytes.
    Nilsson BO
    Inflamm Res; 2007 Jul; 56(7):269-73. PubMed ID: 17659431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hormone replacement Up-to-date. The effect of estrogen on vascular function and atherosclerosis].
    Hayashi T
    Clin Calcium; 2007 Sep; 17(9):1355-63. PubMed ID: 17767024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen is a modulator of vascular inflammation.
    Chakrabarti S; Lekontseva O; Davidge ST
    IUBMB Life; 2008 Jun; 60(6):376-82. PubMed ID: 18409173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular mechanisms underlying the cardiovascular actions of oestrogens.
    Ling S; Komesaroff P; Sudhir K
    Clin Sci (Lond); 2006 Aug; 111(2):107-18. PubMed ID: 16831130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-genomic vascular actions of female sex hormones: physiological implications and signalling pathways.
    Leung SW; Teoh H; Keung W; Man RY
    Clin Exp Pharmacol Physiol; 2007 Aug; 34(8):822-6. PubMed ID: 17600565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Harnessing hormonal signaling for cardioprotection.
    Ballard VL; Edelberg JM
    Sci Aging Knowledge Environ; 2005 Dec; 2005(51):re6. PubMed ID: 16371658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Estrogens and risks for onset of atherosclerosis].
    Tedeschi-Reiner E; Reiner Z
    Lijec Vjesn; 2001; 123(5-6):135-41. PubMed ID: 11554114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.